Work

ACP-103, a 5-HT2A receptor inverse agonist.

Year: 2006

Type: article

Source: PubMed

Author: Claire Roberts

Institution: GlaxoSmithKline (United Kingdom)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2334543757

FWCI: 1.772

Cites:

Cited by: 38

Related to: 10